Varigen Biosciences Corp

Middleton, WI

UEI
XLMBJ8BVWPZ3
CAGE
7LWE7
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3220 Deming Way #160, Middleton, WI 53562, USA
Website
varizymes.com
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
University Of Georgia Development of a CRISPR based amplification assay for the detection of CWD in wild cervids AP24WSNWRC00C026 $127,735

Similar vendors

About the company

Varigen Biosciences Corp is a for-profit corporate entity registered in SAM.gov since 2016, located in Middleton, Wisconsin. The company specializes in developing advanced molecular diagnostic technologies and innovative biotechnology solutions across multiple scientific domains. As a manufacturer of goods, Varigen focuses on creating rapid diagnostic assays, synthetic biology platforms, and novel molecular technologies that address challenges in agriculture, healthcare, and biotechnology research.

Through federal grant awards, Varigen Biosciences Corp has consistently demonstrated expertise in developing sophisticated diagnostic tools and biotechnological innovations. The company has received multiple Small Business Innovation Research (SBIR) grants from agencies including the U.S. Department of Agriculture's National Institute of Food and Agriculture, National Institutes of Health's National Cancer Institute, and National Center for Complementary and Integrative Health. Their grant-funded projects include developing rapid diagnostic assays for detecting avian metapneumovirus, catfish and tilapia pathogens, Hepatitis C virus, Candida auris, and a virulent Aeromonas hydrophila strain. Additionally, they have pursued advanced research in synthetic biology, such as developing fungal transposase systems, discovering antifungal triterpenes, and creating novel DNA polymerase enzymes for next-generation sequencing applications. The company collaborates with academic institutions like the University of Wisconsin, Northwestern University, University of Georgia, and University of Minnesota, indicating a robust research network and interdisciplinary approach to biotechnological innovation.

SBA capabilities narrative

Natural products and molecular biology tools.

Quick answers

Is Varigen Biosciences Corp registered in SAM.gov?

Yes. Varigen Biosciences Corp's SAM.gov registration is active through November 16, 2026.

What is Varigen Biosciences Corp's CAGE code?

Varigen Biosciences Corp's CAGE code is 7LWE7, and its Unique Entity ID (UEI) is XLMBJ8BVWPZ3.

What is Varigen Biosciences Corp's most recent federal award?

Varigen Biosciences Corp's most recent federal grant award is Objective of this project is to develop a diagnostic assay for rapid detection of avian metapneumovirus (AMPV) in… (20254000044935), from Institute of Food Production and Sustainability (NIFA), on August 15, 2025.

On GovTribe

See Varigen Biosciences Corp's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe